Enterprise Value
156.8M
Cash
114.5M
Avg Qtr Burn
-31.8M
Short % of Float
12.43%
Insider Ownership
2.66%
Institutional Own.
55.20%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GRANITE Details Solid tumor/s, Colorectal cancer , Gastric cancer, Cancer Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 2/3 Data readout | |
samRNA Details Infectious disease, COVID-19 | Phase 2b Initiation | |
SLATE Details Solid tumor/s, Colorectal cancer , Lung cancer, Cancer | Phase 2 Initiation |